A Study to Evaluate the Safety, Tolerability, PK and PD of AP303 in DKD Patients
A Study to Evaluate the Safety, Tolerability, PK and PD of AP303 in DKD Patients
Recruiting · NCT06666283 · Registry updated 2025-09-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety, Tolerability, PK and PD of AP303 in DKD Patients | Diabetes Complications, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, diabetes mellitus, diabetic kidney disease, endocrine system disorder, kidney disorder, urinary system disorder | Recruiting | Phase 1 | 2025-09-11 | NCT06666283 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Alebund Pharmaceuticals | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Peking University First Hospital | Beijing | China | 2 |